Disorder of O-N-acetylgalactosaminylglycan synthesis

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:309458
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Disorder of O-N-acetylgalactosaminylglycan synthesis is a group of rare genetic conditions that affect how the body builds certain sugar chains (called glycosaminoglycans or GAGs) that are attached to proteins. These sugar chains are essential building blocks found on the surface of cells and in the spaces between cells throughout the body. They play important roles in cell signaling, tissue structure, and organ development. When the body cannot properly make O-N-acetylgalactosaminylglycan chains, it can lead to problems in multiple organ systems, including the skeleton, joints, skin, heart, and nervous system. This is a category of disorders rather than a single disease, and the specific symptoms depend on which gene is affected and which step in the sugar chain building process is disrupted. Common features may include skeletal abnormalities, short stature, joint problems, developmental delays, and distinctive facial features. Some forms may also affect the heart, eyes, or other organs. Because these are very rare conditions, treatment is mostly supportive and focused on managing individual symptoms. There are currently no specific curative therapies available for most forms. A team of specialists typically works together to address the various body systems that may be involved. Early diagnosis through genetic testing can help guide management and allow families to plan appropriate care.

Key symptoms:

Skeletal abnormalitiesShort statureJoint stiffness or loosenessDevelopmental delayDistinctive facial featuresHeart problemsSkin abnormalitiesVision problemsHearing lossMuscle weaknessBone deformitiesDelayed growthIntellectual disability in some formsRecurrent infections in some forms

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Disorder of O-N-acetylgalactosaminylglycan synthesis.

View clinical trials →

No actively recruiting trials found for Disorder of O-N-acetylgalactosaminylglycan synthesis at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Disorder of O-N-acetylgalactosaminylglycan synthesis community →

No specialists are currently listed for Disorder of O-N-acetylgalactosaminylglycan synthesis.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Disorder of O-N-acetylgalactosaminylglycan synthesis.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Disorder of O-N-acetylgalactosaminylglycan synthesisForum →

No community posts yet. Be the first to share your experience with Disorder of O-N-acetylgalactosaminylglycan synthesis.

Start the conversation →

Latest news about Disorder of O-N-acetylgalactosaminylglycan synthesis

No recent news articles for Disorder of O-N-acetylgalactosaminylglycan synthesis.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What specific subtype of this disorder does my child or I have, and what gene is affected?,Which organs and body systems should be monitored regularly?,How often should we have follow-up appointments and with which specialists?,Are there any clinical trials or research studies we could participate in?,What therapies or interventions can help manage symptoms and improve quality of life?,What is the expected course of this condition over time?,Are other family members at risk, and should they be tested?

Common questions about Disorder of O-N-acetylgalactosaminylglycan synthesis

What is Disorder of O-N-acetylgalactosaminylglycan synthesis?

Disorder of O-N-acetylgalactosaminylglycan synthesis is a group of rare genetic conditions that affect how the body builds certain sugar chains (called glycosaminoglycans or GAGs) that are attached to proteins. These sugar chains are essential building blocks found on the surface of cells and in the spaces between cells throughout the body. They play important roles in cell signaling, tissue structure, and organ development. When the body cannot properly make O-N-acetylgalactosaminylglycan chains, it can lead to problems in multiple organ systems, including the skeleton, joints, skin, heart, a